Neuropsychiatric SLE has no single confirmatory test. Learn why MRI, LP, and EEG are supportive only and how boards test diagnosis by exclusion.
Key takeaway: Neuropsychiatric SLE has no single confirmatory test—MRI, CSF, and EEG can support the diagnosis, but boards expect you to recognize it as a diagnosis of exclusion/attribution.
A 46-year-old female with a history of systemic lupus erythematosus has been lost to follow-up. Apparently, she has failed to fill her medications and has not been keeping up with her appointments. The daughter believes the patient has been using illicit drugs. She comes with a fever of 39°C, severe frontal headaches, confusion, and paranoid ideation. Her laboratory test results show leukopenia, hypocomplementemia and an elevated anti-double-stranded DNA antibody.
Which of the following is a confirmatory test for lupus cerebritis?
Examinees often want one “slam-dunk” study (e.g., MRI or CSF) to confirm neuropsychiatric lupus. The point this question tests is that while MRI abnormalities, inflammatory CSF (pleocytosis/protein), and EEG changes are common, they are nonspecific and can overlap with infection (meningoencephalitis), toxin/drug effects, primary psychiatric disease, metabolic encephalopathy, and cerebrovascular events (including antiphospholipid-related thrombosis). Contemporary consensus and society guidance treat neuropsychiatric SLE as a multimodal diagnosis based on clinical syndrome + supportive studies + exclusion of alternative etiologies rather than a single confirmatory test.
Therefore, E (None of the above) remains the most board-reliable answer: these tests are evaluative/supportive, not confirmatory.
| Option | What It Tests / Implies | Why It’s Wrong Here |
|---|---|---|
| A. CT scan of the head | Rapid rule-out of hemorrhage/mass | Helpful in acute evaluation, but typically insensitive for NPSLE and not confirmatory. |
| B. MRI of the brain | Best imaging for inflammatory/ischemic lesions | Can support NPSLE (white matter lesions, infarcts), but findings are nonspecific and may reflect APS stroke, infection, or other pathology. |
| C. Lumbar puncture | CSF pleocytosis/protein; rule out infection | CSF can be abnormal in NPSLE but also in infection; LP is for exclusion and supportive data, not confirmation. |
| D. EEG | Encephalopathy/seizure tendency | Nonspecific diffuse slowing or epileptiform activity does not confirm NPSLE. |
| E. None of the above | Recognizes lack of a single confirmatory test | Correct: diagnosis is clinical + supportive testing + exclusion of alternatives. |
For neuropsychiatric lupus, MRI/CSF/EEG are supportive and primarily help exclude mimics—none is confirmatory.
The stem “hands you” active SLE (low complement, high anti-dsDNA) and neuropsychiatric symptoms, tempting you to pick the most sophisticated test (MRI). But the word confirmatory is the trap: boards reward recognizing that NPSLE is diagnosed through pattern recognition plus exclusion, not a single definitive study.
A 28-year-old woman with SLE on prednisone and mycophenolate presents with fever, headache, photophobia, and confusion. Which test is most urgent to help exclude a key alternative diagnosis before attributing symptoms to NPSLE?
A 40-year-old woman with SLE develops sudden right-sided weakness and aphasia. MRI shows an acute left MCA infarct. Which additional finding most strongly supports antiphospholipid syndrome as the mechanism rather than inflammatory NPSLE?
A 33-year-old woman with SLE has agitation, paranoia, and insomnia starting 5 days after a prednisone dose increase to 60 mg/day. Afebrile; normal complement and stable anti-dsDNA. Most likely explanation?
A 45-year-old with known SLE presents with fever, confusion, and headache. Exam shows nuchal rigidity. What is the best next step?
Compare two SLE patients with acute confusion: one with fever and nuchal rigidity, and one who became psychotic after a major prednisone escalation—how does your diagnostic sequencing differ, and what “can’t-miss” etiologies change immediate management?
Q1: Is “lupus cerebritis” a distinct diagnosis with a specific test?
A: No. The ABIM-style expectation is that neuropsychiatric SLE is an attribution diagnosis supported by studies but not confirmed by any single test.
Q2: Why isn’t MRI considered confirmatory if it’s often abnormal?
A: Because MRI abnormalities (white matter lesions, infarcts) are nonspecific and overlap with APS thrombosis, infection, migraine, small vessel disease, and other inflammatory conditions—boards test specificity.
Q3: What is the role of lumbar puncture in suspected NPSLE?
A: Primarily to exclude infection and to gather supportive inflammatory data; it does not definitively establish NPSLE.
Q4: What competing diagnosis is especially board-relevant in SLE with stroke symptoms?
A: Antiphospholipid syndrome–related thrombosis; the ABIM expects you to distinguish thrombotic stroke from inflammatory NPSLE processes.
This question appears in Med-Challenger Internal Medicine Review with CME
Try for free and save. Ace your exams and meet your CME/MOC requirements for just $35 a month!
No matter your program, no matter the size, Med-Challenger for Groups and Institutions can better prepare your program or group, fulfill industry requirements, and increase test scores.
Severe primary hypothyroidism can cause TRH-driven pituitary hyperplasia that mimics a sellar mass. Learn the lab patterns boards test.
Learn why melena—not anemia—is the key symptom of right-sided colon cancer in this week’s most-missed PA exam question and what it teaches...
Most Missed Question in Emergency Medicine: applying modified Sgarbossa criteria for LBBB/STEMI — high-yield exam prep and key test-taking tip.